U.S. Exchanges

List of Publicly Traded Health Insurance and Health Care Plan

Analyze the 2026 landscape of health plan providers, featuring enrollment rankings and market cap data for leaders in Medicare Advantage and Medicaid managed care.

52M Top Enrollment (UNH)
87.5% Avg Medical Loss Ratio
-2.3% 2026 CMS Rate Change
Apr 2026 Last Updated
This page is for informational and educational purposes only and does not constitute investment advice. Always consult a qualified financial professional before making investment decisions.

The List of Publicly Traded Health Insurance and Health Care Plan providers identifies the primary organizations managing medical risk for over 150 million Americans. As of April 2026, the sector is defined by a massive shift toward government-sponsored programs, with Medicare Advantage and Medicaid managed care (MCO) now representing the majority of industry growth. Investors often monitor these firms within the broader List of Insurance Companies to compare risk-adjusted returns against life and property casualty peers. Market leaders like UnitedHealth (UNH #1 52M members) continue to leverage vertical integration to manage rising Medical Loss Ratios (MLR). Understanding the regulatory environment, including CMS reimbursement pivots and ACA exchange fluctuations, is vital for evaluating long-term stability in the health plan space.

Key Takeaways

01 Medicare Advantage Dominance

Government-sponsored Medicare Advantage (MA) plans now account for over 50% of the Medicare market, with Humana (HUM MA specialist) and UNH controlling nearly half of total enrollment.

02 MLR as a Profit Driver

The Medical Loss Ratio (MLR) averaged 87.5% in 2025. Firms that successfully manage claims costs below the 85% corridor in ACA exchanges generally see superior margin expansion.

03 Medicaid MCO Penetration

Medicaid managed care has reached 60% penetration. Centene (CNC Medicaid leader) remains the dominant player, managing risk for over 28 million Medicaid members.

04 Vertical Integration Trend

Consolidation has shifted the landscape, notably the Aetna-CVS merger, allowing plans to integrate pharmacy benefit management (PBM) and care delivery under one corporate umbrella.

Top List of Publicly Traded Health Insurance and Health Care Plan by Market Cap (2026)

Ranking the 2026 leaders by enrollment scale and market valuation, reflecting a sector heavily concentrated in diversified managed care giants.

Rank Ticker Company Total Members Market Cap YTD % 2025 MLR Primary Focus
1 UNH UnitedHealth Group 52.0M $450B +6.0% 87.2% Diversified
2 ELV Elevance Health 47.0M $110B +4.5% 87.8% Blue Cross
3 CVS CVS Health (Aetna) 36.0M $100B +3.2% 88.1% Integrated
4 CI Cigna Group 18.0M $95B +12.0% 86.5% Commercial
5 CNC Centene Corp. 28.0M $40B +5.4% 88.5% Medicaid
6 HUM Humana Inc. 17.0M $35B -2.1% 89.2% Medicare
7 MOH Molina Healthcare 15.0M $22B +18.0% 88.2% Medicaid
8 OSCR Oscar Health 1.5M $4.3B +14.5% 84.0% Tech/ACA
9 ALHC Alignment Health 0.2M $1.8B +8.0% 86.5% Medicare
Market data is approximate and for informational purposes only. Data reflects early Q2 2026 figures. Enrollment scale sourced from CMS and KFF 2026 reports. Health Insurance Industry Comparison Widget.

List of Publicly Traded Health Insurance and Health Care Plan — Complete Company List

Mid-Cap Companies

Health Insurance: Large-Cap Stocks

Health Insurance: Mid-Cap Stocks

Health Insurance: Micro-Cap Stocks

Corporate Rebranding & Merger Timeline

Legacy Name Old Ticker Current Ticker Year Impact / Status
Aetna AET CVS 2018 Acquired by CVS Health ($69B)
Anthem ANTM ELV 2022 Rebranded to Elevance Health
WellCare WCG CNC 2020 Merged with Centene
Cigna CI CI 2023 Rebranded to The Cigna Group

Risks & Considerations

CMS Reimbursement Rate Pressure

Medicare Advantage providers face a -2.3% reimbursement cut in 2026. Firms with low Star Ratings are particularly vulnerable to margin compression as federal quality bonuses decline.

Medicaid Redetermination Churn

Post-pandemic redeterminations have caused significant membership churn in the Medicaid segment. Companies like Centene and Molina must manage these eligibility shifts to maintain revenue stability.

Regulatory & ACA Policy Shifts

The health insurance market is highly sensitive to political changes. A "subsidy cliff" in ACA exchanges or changes to risk adjustment models can instantly alter the profitability of individual market plans.

Rising Medical Loss Ratios (MLR)

An unexpected surge in medical utilization or high-cost pharmaceutical launches (e.g., GLP-1s) can drive MLRs above projected levels, leading to immediate quarterly earnings misses across the sector.

These risk factors are for educational purposes only and are not exhaustive. Individual investment decisions should be based on thorough due diligence.

Frequently Asked Questions

UnitedHealth (UNH $450B), Elevance (ELV $110B), CVS/Aetna (CVS $100B), and Cigna Group (CI $95B) lead the industry by market valuation and enrollment scale.
Aetna (AET) was delisted following its $69 billion acquisition by CVS Health in 2018. Aetna now serves as the insurance arm of the vertically integrated CVS Health.
UnitedHealth leads with 29% of the MA market, followed by Humana (17%) and Elevance (12%). The sector is currently navigating reimbursement cuts from CMS.
Centene (CNC) holds a 25% share of the Medicaid MCO market, with Molina (MOH) controlling roughly 12%. Both are primary plays for Medicaid-focused portfolios.
Molina Healthcare (+18%) and Cigna (+12%) have led the sector YTD in 2026, benefiting from a rotation into companies with strong commercial and Medicaid managed care execution.
The Medical Loss Ratio (MLR) measures the percentage of premium revenue spent on claims. The industry average is currently 87.5%, with regulatory corridors usually set at 80-85%.
Anthem (ANTM) rebranded to Elevance Health (ELV) in 2022 to reflect its pivot toward whole-health and digital services beyond traditional insurance.
Centene’s Ambetter brand maintains a 40% market share in the ACA exchanges. Tech-forward Oscar Health (OSCR) is also a significant player in this high-growth segment.
Last updated April 2026 · Data sourced from U.S. exchange filings
```